Clinical Trials Logo

Depression clinical trials

View clinical trials related to Depression.

Filter by:

NCT ID: NCT06115200 Not yet recruiting - Depression Clinical Trials

Norwegian Adult Mental Health Registry

NAMHR
Start date: January 1, 2024
Phase:
Study type: Observational [Patient Registry]

"The Norwegian Adult Mental Health Registry" (NAMHR) is a medical quality register collecting and systematizing data on patients and their treatment in specialist mental health care for adults in Norway. The main purpose is to create a documentation basis for quality assurance, evaluation, and improvement of assessment and treatment for patients who are offered treatment for mental disorders in the specialist health service. The register uses automatic data capture from various existing data sources. New patients are automatically included, but given the opportunity for reservations from the register without affecting their services and treatment.

NCT ID: NCT06113029 Not yet recruiting - Depression, Anxiety Clinical Trials

Depressive and Anxiety Disorders in Patients With Chronic Liver Diseases

Start date: December 1, 2023
Phase:
Study type: Observational

The aim of this observational study is to learn about the prevalence of depressive and anxiety disorders among patients with chronic liver diseases

NCT ID: NCT06112457 Not yet recruiting - Clinical trials for Anxiety Depression Disorder

Anxiety and Depression Among Gendarmes Posted to French Guiana

TAD-GENDGF
Start date: November 2023
Phase:
Study type: Observational [Patient Registry]

This is a mixed-method, single-center study involving two concurrent phases: a quantitative phase with an anonymous self-administered questionnaires, and a qualitative phase with individual contextual interviews and a focus group. The hypothesis underlying this study is that isolated postings are a risk factor for anxiety-depressive disorders. The aim of this study is to provide new information to help propose targeted prevention and health promotion measures.

NCT ID: NCT06110715 Not yet recruiting - Depression Clinical Trials

Quantifying tACS-driven Improvement of Working Memory in Depression

Start date: August 1, 2024
Phase: N/A
Study type: Interventional

TACS is an emergent method of non-invasive neuromodulation which can engage frequency-specific brain oscillations. It is increasingly recognized that neural oscillations play a system-organizing role in the brain. Evidence suggests that disorganized neural oscillations may also influence functionality of cognitive processes such as working memory. Thus, as TACS can affect neural oscillatory activity in the human brain in a non-invasive manner, it has promise to transform mental health care. The premise of this proposed work is that tACS concurrent with multi-session working memory (WM) focused skills will facilitate durable working memory and stabilized neural oscillations. Depression offers an excellent model to study the effects of tACS. The study seeka to administer 2mA of tACS using theta oscillations to improve working memory concerns associated with depression. The purpose of this study is to investigate the electrophysiological and behavioral effects of transcranial alternating current stimulation (tACS) in humans and to explore specific improvements in working memory and depressive symptoms. This study is placebo-controlled study. Participants will undergo pre- and post-assessments and either theta or sham tACS for 5 days. During each session, the volunteer will perform cognitive tasks while receiving tACS. Assessment sessions will include cognitive tasks, questionnaires, a clinical interview, and EEG.

NCT ID: NCT06105762 Not yet recruiting - Clinical trials for Major Depressive Disorder

Ketogenic Diet for Depression

KETO-MOOD
Start date: January 1, 2024
Phase: N/A
Study type: Interventional

Globally, it's estimated that around 300 million people are affected by depressive illness, and even with access to modern mental health care, long-term recovery is uncommon. Recently, there has been increasing interest in a promising intervention: the ketogenic diet. This diet restricts carbohydrate intake, promoting the breakdown of fats into circulating ketone bodies, which can act as an additional energy source for the brain, potentially reducing its reliance on glucose. While various sources of evidence suggest the potential benefits of the ketogenic diet for individuals with depression, robust clinical studies on its efficacy in depressed patients are lacking. Our goal is to conduct an eight-week, assessor-blinded, randomized controlled trial to investigate the therapeutic effects of a very low-carbohydrate, high-fat ketogenic diet compared to an active comparator diet in individuals with depression.

NCT ID: NCT06101914 Not yet recruiting - Clinical trials for Treatment Resistant Depression

Studying Patterns in Patient Engagement Among Treatment Resistant Depression Patients

Start date: November 2024
Phase:
Study type: Observational

Clinical studies, with a distinct focus on treatment resistant depression, play a crucial role in evaluating the safety and effectiveness of novel treatments. These trials serve as instrumental means to determine whether new medications surpass conventional therapies, providing substantial evidence for their broader adoption. The primary objective is to meticulously scrutinize trial completion rates and voluntary withdrawals within this specific patient group.

NCT ID: NCT06098469 Not yet recruiting - Depression Clinical Trials

Developping a a Brain-controlled Art App to Ease Residual Symptoms of Depression

DEEPBLUE
Start date: April 2024
Phase: N/A
Study type: Interventional

The study evaluate the effect of 10 neurofeedback sessions on the residual symptoms of depressive patients in partial remission.

NCT ID: NCT06095310 Not yet recruiting - Depression Clinical Trials

Clinical and Objective Psychiatric Analyses in Severe Depression.

CALYPSO
Start date: November 2023
Phase: N/A
Study type: Interventional

Participation in the CALYPSO project will be offered to all patients with severe depression hospitalized in the adult psychiatry department of Lille CHU. An initial visit will provide a standardized clinical assessment with: a medical history and history of the disease, a standardized structured Hamilton scale interview (scale with a score from 0 to 21; the higher the score, the more severe the depression) to assess the severity of depression, and a search for the different features of severe depression (melancholic, psychotic, anxious, catatonic, seasonal) using DSM-5 criteria (list of criteria to be validated to determine the type of clinical features). When assessing the severity of depression using the Hamilton scale interview, the patient will be seated in an armchair 2 to 3 meters from a camera on a tripod, positioned behind the clinician and enabling the entire interview to be recorded and, in particular, several observable and measurable psychiatric signs and symptoms, known as objective markers. From the video will be extracted face landmark and pose parameter using state-of-the-art open source software (Mediapipe) to analyze patients' emotional facial expressions and spatial movements. Moreover, a microphone will be used to capture the audio synchronously with the video. Speech will be automatically transcoded using state-of-the-art Automatic Speech Recognition system (DeepSpeech) to enable analysis of voice-related parameters (voice timbre, prosody, sound intensity). A recording of physical activity (3-axis accelerometer sensor; 32 Hz) and emotional reactivity (heart rate in beats per minute 1Hz; electrodermal activity 4 Hz; skin temperature in degrees 4 Hz; Empatica© bracelet) and brain activity (cerebral blood flow change index 10Hz; pulse rate in bpm 10Hz; 3-axis acceleration and angular velocity of the head 10Hz via functional Near-Infrared Spectroscopy (fNIRS) using a HOT-2000 wearable headset) will also be offered to the patient to complete the assessment. The Hamilton scale interview and recording of objective markers will be carried out weekly during the patient's hospitalization in an examination room specifically equipped for the project, on the second floor of the Fontan Hospital, in the psychiatry department of the Lille University hospital. Longitudinal follow-up will be carried out with assessments at 3, 6 and 12 months after hospital discharge, including the Hamilton scale interview and recording of objective markers (i.e., emotional facial expressions, spatial movements, voice timbre, prosody, sound intensity, physical activity, heart rate, electrodermal activity, skin temperature).

NCT ID: NCT06094088 Not yet recruiting - Depression Clinical Trials

Examining the Impact of Heated Yoga on Mindfulness and Rumination

RHYME
Start date: April 1, 2024
Phase: N/A
Study type: Interventional

This study will examine how doing heated yoga or non-heated yoga affects depression.

NCT ID: NCT06093282 Not yet recruiting - Depression Clinical Trials

Activity and Recreation in Communities for Health

ARCH
Start date: June 1, 2024
Phase: N/A
Study type: Interventional

This project tests whether a health outreach intervention that promotes engagement in rewarding, community-based recreational and social activities can produce greater improvements in depressive symptoms, adiposity, and physical activity among people from underresourced communities than traditional health outreach approaches.